bibliographicCitation |
Ruane P, Alas B, Ryan R, Perniciaro A, Witek J. A 48-week pilot study switching suppressed patients to darunavir/ritonavir and etravirine from enfuvirtide, protease inhibitor(s), and non-nucleoside reverse transcriptase inhibitor(s). AIDS Res Hum Retroviruses. 2010 Nov;26(11):1215–9. doi: 10.1089/aid.2009.0285. PMID: 21083412. |